Effect of Cervical Epidural Analgesia on the Occurrence of Pharyngocutaneous Fistula
Cutaneous Fistula, Laryngectomy
About this trial
This is an interventional prevention trial for Cutaneous Fistula focused on measuring cervical epidural, laryngectomy, pharyngocutaneous fistula
Eligibility Criteria
Inclusion Criteria:
- Patients who failed treatment with radiotherapy for laryngeal cancer
Exclusion Criteria:
- Infection at the site of flap
- Primary laryngectomy without radiotheraapy
Sites / Locations
- DiabRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
EP, Cervical epidural group
GA, General anesthesia
patients undergoing salvage laryngectomy (failed radiotherapy to treat laryngeal cancer) will receive cervical epidural analgesia in addition to the standard general anesthesia (induction with propofol 2 mg / kg, endotracheal intubation facilitated by cis-atracurium 0.3 mg / kg and 0.15 mg /kg on demand and maintained with inhalational anesthetic sevoflurane) Cervical epidural technique: epidural needle will be inserted at C 6-C7 or C7-T1 under fluoroscopy in prone position, 6 ml of 0.125% bupivacaine and fentanyl 2 mic/ ml will be administered before skin incision followed by 4 ml of the same injectate, will be infused continously for 2 days
patients undergoing salvage laryngectomy (failed radiotherapy to treat laryngeal cancer) will receive standard general anesthesia only (induction with propofol 2 mg / kg, endotracheal intubation facilitated by cis-atracurium 0.3 mg / kg and 0.15 mg /kg on demand and maintained with inhalational anesthetic sevoflurane) in addition to postoperative analgesia through patient controlled intravenous morphine analgesia (PCA), that involve 1 mg continuous infusion and 2 mg boluses with lockout interval 10 min